Icon profits up 17% to €86m

IRISH pharmaceutical services company and clinical trials specialist, Icon, has reported a 17% increase in full-year operating profit to $116 million (€86m) for last year.

Icon profits up 17% to €86m

Net revenue also rose by 3% to $888m.

Full-year diluted earnings per share amounted to $1.53, 18% growth on the previous year.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited